Expression of noncoding vault RNA in human malignant cells and its importance in mitoxantrone resistance

Molecular Cancer Research

Volumn 8, Issue 11, 2010, Pages 1536-1546

  Gopinath, Subash C B ^a   Wadhwa, Renu ^a   Kumar, Penmetcha K R ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MITOXANTRONE; UNCLASSIFIED DRUG; UNTRANSLATED RNA; VAULT RNA;

ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; GENE CONTROL; GENE OVEREXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; LEUKEMIA; OSTEOSARCOMA; PRIORITY JOURNAL; RNA INTERFERENCE;

ANTINEOPLASTIC AGENTS; BASE SEQUENCE; BONE NEOPLASMS; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; LEUKEMIA; MITOXANTRONE; MOLECULAR SEQUENCE DATA; OSTEOSARCOMA; RNA INTERFERENCE; RNA, SMALL INTERFERING; RNA, UNTRANSLATED; U937 CELLS; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 78649639048     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-10-0242     Document Type: Article

References (26)

1. Kedersha NL, Heuser JE, Chugani DC, Rome LH. Vaults. III. Vault ribonucleoprotein particles open into flower-like structures with octagonal symmetry. J Cell Biol 1991;112:225-35.
2. Abbondanza C, Rossi V, Roscigno A, et al. Interaction of vault particles with estrogen receptor in the MCF-7 breast cancer cell. J Cell Biol 1998;141:1301-10.
3. Herrmann C, Golkaramnay E, Inman E, Rome L, Volknandt W. Recombinant major vault protein is targeted to neuritic tips of PC12 cells. J Cell Biol 1999;144:1163-72.
4. van Zon A, Mossink MH, Scheper RJ, Sonneveld P, Wiemer EAC. The vault complex. Cell Mol Life Sci 2003;60:1828-37.
5. Kitazono M, Sumizawa T, Takebayashi Y, et al. Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells. J Natl Cancer Inst 1999;91:1647-53.
6. Kickhoefer VA, Rajavel KS, Scheffer GL, Dalton WS, Scheper RJ, Rome LH. Vaults are up-regulated in multidrug-resistant cancer cell lines. J Biol Chem 1998;273:8971-4.
7. Siva AC, Raval-Fernandes S, Stephen AG, et al. Up-regulation of vaults may be necessary but not sufficient for multidrug resistance. Int J Cancer 2001;92:195-202.
8. van Zon A, Mossink MH, Schoester M, et al. Multiple human vault RNAs. Expression and association with the vault complex. J Biol Chem 2001;276:23217-20.
9. Poderycki MJ, Rome LH, Harrington L, Kickhoefer VA. The p80 homology region of TEP1 is sufficient for its association with the telomerase and vault RNAs, and the vault particle. Nucleic Acids Res 2005;33:893-902.
10. Huffman KE, Corey DR. Major vault protein does not play a role in chemoresistance or drug localization in a non-small cell lung cancer cell line. Biochemistry 2005;44:2253-61.
11. Steiner E, Holzmann K, Elbling L, Micksche M, Berger W. Cellular functions of vaults and their involvement in multidrug resistance. Curr Drug Targets 2006;7:923-34.
12. Kickhoefer VA, Liu Y, Kong LB, et al. The Telomerase/vault-associated protein TEP1 is required for vault RNA stability and its association with the vault particle. J Cell Biol 2001;152:157-64.
13. Tanaka H, Kato K, Yamashita E, et al. The structure of rat liver at 3.5 angstrom resolution. Science 2009;322:384-8.
14. Roninson IB. In: Roninson IB, editor. Molecular and cellular biology of multidrug resistance in tumour cells. New York: Plenum Press; 1991, p. 1-406.
15. Hu Y, Stephen AG, Cao J, et al. A very early induction of major vault protein accompanied by increased drug resistance in U-937 cells. Int J Cancer 2002;97:149-56.
16. Ohno N, Tani A, Uozumi K, et al. Expression of functional lung resistance-related protein predicts poor outcome in adult T-cell leukemia. Blood 2001;98:1160-5.
17. Mossink MH, van Zon A, Scheper RJ, Sonneveld P, Wiemer EAC. Vaults: a ribonucleoprotein particle involved in drug resistance? Oncogene 2003;22:7458-67.
18. Gopinath SCB, Matsugami A, Katahira M, Kumar PKR. Human vault-associated non-coding RNAs bind to mitoxantrone, a chemotherapeutic compound. Nucleic Acids Res 2005;33:4874-81.
19. Wang HW, Wu HL, Chen DS, Chen PJ. Identification of the functional regions required for hepatitis virus replication and transcription by linker-scanning mutagenesis of viral genome. Virology 1997;239:119-31.
20. Nissen P, Hansen J, Ban N, Moore PB, Steitz TA. The structural basis of ribosome activity in peptide bond synthesis. Science 2000;289:920-30.
21. Mallory AC, Dugas DV, Bartel DP, Bartel B. MicroRNA regulation of NAC-domain targets is required for proper formation and separation of adjacent embryonic, vegetative, and floral organs. Curr Biol 2004;14:1035-46.
22. Mandal M, Breaker RR. Adenine riboswitches and gene activation by disruption of a transcription terminator. Nat Struct Mol Biol 2004;11:29-35.
23. Wadhwa R, Takano S, Kaur K, et al. Upregulation of mortalin/mthsp70/Grp75 contributes to human carcinogenesis. Int J Cancer 2006;118:2973-80.
24. Li L, Okino ST, Zhao H, et al. Small dsRNAs induce transcriptional activation in human cells. Proc Natl Acad Sci U S A 2006;103:17337-42. (Pubitemid 44788970)
25. kip1. J Biol Chem 2008;283:29897-903.
26. Tsang WP, Wong TWL, Cheung AHH, Co CNN, Kwok TT. Induction of drug resistance and transformation in human cancer cells by the non-coding RNA CUDR. RNA 2008;13:890-8.